China Biosimilars Market Key Priority Areas Of Action And Enhancing Risk Management Capacities 2022-2025
China biosimilars market was valued at $687.6 million in 2017 and is expected to reach $5,506.2 million by 2025 with a CAGR of 29.7% PORTLAND, OREGON, UNITED STATES, August 18, 2022 /EINPresswire.com/ -- According to the report by Allied Market …